Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents

Puntos clave

• The aim is to assess the effectiveness of anticoagulation therapy in patients with atrial fibrillation who have drug-eluting stents.
• Randomized trial design with participants receiving either anticoagulation or standard care.
• Evaluation of cardiovascular outcomes among patients post-percutaneous coronary intervention.
• Follow-up duration included in the study to assess long-term effects.
• Patients on anticoagulation therapy showed a significant reduction in thromboembolic events (HR 0.65, 95% CI 0.45-0.95, p=0.03).
• Incidence of major bleeding was similar between the two groups (RR 1.05, 95% CI 0.70-1.30, p=0.80).
• Quality of life improvements were reported in the anticoagulation group.